TTD | Drug: D0SY6T

Drug General Information
Drug ID	D0SY6T
Former ID	DNC014629
Drug Name	1-(3,3-Diphenyl-allyl)-3-m-tolyl-urea
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527275]
Structure		Download 2D MOL 3D MOL
Formula	C23H22N2O
Canonical SMILES	CC1=CC(=CC=C1)NC(=O)NCC=C(C2=CC=CC=C2)C3=CC=CC=C3
InChI	1S/C23H22N2O/c1-18-9-8-14-21(17-18)25-23(26)24-16-15-22(19-10-4-2-5-11-19)20-12-6-3-7-13-20/h2-15,17H,16H2,1H3,(H2,24,25,26)
InChIKey	AQCRRYHNTDGOLK-UHFFFAOYSA-N
PubChem Compound ID	44265928
Target and Pathway
Target(s)	Cholecystokinin receptor type A	Target Info	Inhibitor	[527275]
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Insulin secretion
	Pancreatic secretion
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (q) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 527275	J Med Chem. 1992 Mar 20;35(6):1042-9.Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
Ref 527275	J Med Chem. 1992 Mar 20;35(6):1042-9.Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information